What is Wayovy?
Wegovy is a prescription drug from Novo Nordisk for the treatment of obesity and obesity. It contains the same active ingredient as Ozempic – Semaglutid – but is specifically approved for weight reduction and dosed higher.
The difference to Ozempic:
- Ozempic: Approved for diabetes, max. 2 mg
- Wegovy: Approved for weight reduction, max. 2.4 mg
Wegovy is injected into the skin once a week and has shown average weight loss of about 15% of body weight in studies – significantly more in some patients.
The drug acts via the body's hormone GLP-1, which signals saturation and reduces appetite. Many users report that they are less hungry and are fed up faster.
Active Ingredients & Mechanism of Action
Active ingredient: Semaglutid
Semaglutid imitates the body's hormone GLP-1 (glucagon-like peptides-1):
**1. Appetite regulation in the brain:* * GLP-1 receptors in hypothalamus are activated. This leads to increased saturation and reduced hunger.
**2. Slow gastric emptying:* * The stomach drains more slowly. They feel tired longer and eat less automatically.
**3. Changed food preferences:* * Many users report that they have less desire for fat or sweet food.
The result:
- Significantly reduced appetite
- Smaller portions are enough
- Less cravings
- Automatic lower calorie intake
Study results (STEP studies):
- Average weight loss: 15% of body weight
- About 1/3 of participants lost more than 20%
- Improving blood pressure, cholesterol and blood sugar
Who is it suitable for?
Approved indication:
- BMI ≥ 30 (obesity) OR
- BMI ≥ 27 with at least one weight-related accompanying disease (blood high pressure, type 2 diabetes, increased blood fat, sleep apnea)
Provisions:
- Nutrition and exercise therapy alone were not sufficient
- readiness to change lifestyle
- No contraindications
More suitable:
- Type 1 diabetes
- Pregnancy or planned pregnancy
- History of pancreatitis
- Heavy gastrointestinal diseases
- Medulläres thyroid carcinoma in family
Important: Wegovy is not a lifestyle drug. It is intended for people with medically relevant overweight that endanger their health.
Available Dosages
dosing scheme:
- Weeks 1-4: 0.25 mg once a week
- Weeks 5-8: 0.5 mg once a week
- Weeks 9-12:** 1 mg once a week
- Weeks 13-16:** 1.7 mg once a week
- From week 17: 2.4 mg once a week (maintenance dose)
**Why slow dosing? * * The step-by-step increase significantly reduces gastrointestinal side effects. Nausea and vomiting are common at the beginning, but better with time.
For poor compatibility: If 2.4 mg is not tolerated, it can remain at 1.7 mg.
Available pens: Each dose level has its own prefilled pen with 4 injections for 4 weeks.
How to Take
Application:
- One week, the same weekday
- Subcutaneous injection (under the skin)
- Possible places: belly, thigh, thigh
- Independent meals
Injection technology: 1. Take pen from the refrigerator Two. New needle 3. Form the skin fold and insert the needle 4. Press injection button and hold 6 seconds Five. Remove and remove needle
If you want to change the day: At least 2 days between injections.
Forget dose:
- Within 5 days: Repeat
- After 5 days: omit, next regular dose
Restoration:
- Unopened: fridge (2-8°C)
- After rupture: up to 6 weeks at room temperature or in the refrigerator
Contraindications
Absolute contraindications:
- hypersensitivity to semaglutide
- Medulläres thyroid carcinoma in prehistory
- Multiple endocrine neoplasia type 2 (MEN 2) in the family
- Pregnancy and breastfeeding
Relative contraindications:
- History of pancreatitis
- Heavy kidney failure
- Heavy gastronomic diseases
- Diabetic retinopathy (narrow control)
Preview at:
- Type 2 diabetes with insulin or sulfonylureas (hypoglycemia risk)
- Gallensteinleiden
- Sufficient to depression
Possible Side Effects
Very common (>10%):
- nausea (especially at the beginning)
- diarrhea
- Blocking
- Break.
- stomach pain
Acid (1-10%):
- Headaches
- fatigue
- Blowing
- Sodburning
- Repulse
- Squeeze
- gallstones
Occasionally:
- Increased heart rate
- Reactions at the injection site
- Changes in taste
Selten, but seriously:
- Pancreatitis (strong abdominal pain)
- Heavy allergic reactions
- Acute kidney failure in dehydration
Tips against nausea:
- Slowly dosing
- Small meals
- Avoid fat food
- Eat slowly
- Drink enough
Interactions
Insulin and sulfonylureas:
- Increased hypoglycemia risk in diabetics
- Dose reduction of these drugs often necessary
Oral medicines:
- Slowed gastric emptying can affect absorption
- Relevant for time-critical drugs
Oral contraceptives:
- Additional prevention with strong GI side effects
Warfarin:
- INR controls at therapy start
Frequently Asked Questions
Similar Medications
Is Wayovy right for you?
A licensed doctor will review your information and issue a prescription if suitable. Discreet and secure.
Important Notice
This information does not replace medical advice. If you have questions about your health or the suitability of this medication, please consult a doctor or pharmacist.
Important Safety Information
This service operates under German pharmaceutical law (HWG). For risks and side effects, read the package leaflet and consult your doctor or pharmacist. All medications are dispensed from a licensed pharmacy in Germany.